Chemoprophylaxis with tenofovir disoproxil fumarate provided partial protection against infection with simian human immunodeficiency virus in macaques given multiple virus challenges.
about
Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT miceTenofovir-based pre-exposure prophylaxis for HIV preventionPreexposure prophylaxis for HIV prevention: where have we been and where are we going?Practical guidance for nonoccupational postexposure prophylaxis to prevent HIV infection: an editorial reviewSIV infection of rhesus macaques of Chinese origin: a suitable model for HIV infection in humansAntiretrovirals for primary HIV prevention: the current status of pre- and post-exposure prophylaxisStampidine as a promising antiretroviral drug candidate for pre-exposure prophylaxis against sexually transmitted HIV/AIDSTenofovir disoproxil fumarate for prevention of HIV infection in women: a phase 2, double-blind, randomized, placebo-controlled trialPrevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovirSystemic administration of antiretrovirals prior to exposure prevents rectal and intravenous HIV-1 transmission in humanized BLT micePrevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gelEnrollment characteristics and risk behaviors of injection drug users participating in the Bangkok Tenofovir Study, ThailandFactors influencing the emergence and spread of HIV drug resistance arising from rollout of antiretroviral pre-exposure prophylaxis (PrEP)T cell chemo-vaccination effects after repeated mucosal SHIV exposures and oral pre-exposure prophylaxisPre-exposure prophylaxis for the prevention of HIV infection in high risk populations: a meta-analysis of randomized controlled trialsTopical Delivery of Tenofovir Disoproxil Fumarate and Emtricitabine from Pod-Intravaginal Rings Protects Macaques from Multiple SHIV ExposuresAntiretroviral Drug Activity in Macaques Infected during Pre-Exposure Prophylaxis Has a Transient Effect on Cell-Associated SHIV DNA ReservoirsCharacteristics of HIV-1 serodiscordant couples enrolled in a clinical trial of antiretroviral pre-exposure prophylaxis for HIV-1 preventionSurrogates of protection in repeated low-dose challenge experiments.Assessing vaccine effects in repeated low-dose challenge experiments.HIV-prevention science at a crossroads: advances in reducing sexual risk.Potential impact of antiretroviral chemoprophylaxis on HIV-1 transmission in resource-limited settingsAntiretroviral therapy for prevention of HIV infection: new clues from an animal model.The impact of pre-exposure prophylaxis (PrEP) on HIV epidemics in Africa and India: a simulation study.Development of topical microbicides to prevent the sexual transmission of HIVOral pre-exposure prophylaxis by anti-retrovirals raltegravir and maraviroc protects against HIV-1 vaginal transmission in a humanized mouse model.Evaluation of pigtail macaques as a model for the effects of copper intrauterine devices on HIV infection.Antiretroviral drug exposure in the female genital tract: implications for oral pre- and post-exposure prophylaxisInternational multicenter study to assess a panel of reference materials for quantification of simian immunodeficiency virus RNA in plasmaHIV, transmitted drug resistance, and the paradox of preexposure prophylaxis.Tenofovir diphosphate concentrations and prophylactic effect in a macaque model of rectal simian HIV transmission.A polyvalent Clade B virus-like particle HIV vaccine combined with partially protective oral preexposure prophylaxis prevents simian-human immunodeficiency virus Infection in macaques and primes for virus-amplified immunityPreclinical evaluation of the immunomodulatory lymphocyte trafficking drug FTY720 for HIV prevention in the female genital mucosa of macaquesPrevention of vaginal SHIV transmission in macaques by a coitally-dependent Truvada regimen.Increased susceptibility to vaginal simian/human immunodeficiency virus transmission in pig-tailed macaques coinfected with Chlamydia trachomatis and Trichomonas vaginalisAIDS vaccines and preexposure prophylaxis: is synergy possible?Long-acting integrase inhibitor protects macaques from intrarectal simian/human immunodeficiency virus.Pre-exposure prophylaxis of HIV: A right way to go or a long way to go?Natural substrate concentrations can modulate the prophylactic efficacy of nucleotide HIV reverse transcriptase inhibitors.Protection against rectal transmission of an emtricitabine-resistant simian/human immunodeficiency virus SHIV162p3M184V mutant by intermittent prophylaxis with Truvada.
P2860
Q21144657-EFD4FF4F-C4D3-478A-A774-107C399154B1Q22242692-63F35AC3-95D6-4F52-94F9-130DAF66EA19Q26825042-89476F8C-1E11-454D-AF90-C6B553C828C6Q26853055-30E2F70C-B811-450A-8B2F-53FFE52DD2C9Q27014903-B47B9BF6-846F-4D3B-A60A-DFEFCB046E3BQ28085433-36623C4E-C576-4F5B-B434-A8C0E1BC1759Q28260539-022AF59F-706D-49F1-9A87-1E6A9FC62A05Q28469218-859ACB4B-0F11-4E52-BEF6-4A80680CFD14Q28472146-BAEAB9C4-519B-4EC9-95AE-A20E66B15E55Q28472590-68B755A7-62B8-4025-8419-E721ACB2B074Q28473376-1533B4A3-ABB5-4D89-87D3-F9371470D8A4Q28477258-FA422A1A-DAB9-439D-B0A1-0C8CE57F82E1Q28477780-943F225E-C95C-4580-8C3A-0535F09ED57DQ28477909-71299ED9-1162-4D29-923A-F461EF43801EQ28539443-E9EF75EF-A79F-4B1B-AD76-AF428944EC07Q28550108-18ECEA3E-0352-407F-B290-28CC03BE115CQ28553127-878CEC8F-5BB7-49A3-8FAC-91147FC89A8CQ28744206-7E4A734E-EF78-4DAA-B3C5-AA95B2820D49Q30371157-94DA25FA-7178-454E-BD55-971AAEAE19B5Q30376557-623507BD-89A7-4D3A-8D48-E84D23D3185CQ30378142-E5A78098-BB12-49A7-8BFC-BF52EE0C7F23Q33299456-8ACEF2DC-BBEB-46B0-AD1D-107228A5AAF7Q33318541-9F30A3D0-2017-4CE8-A443-278C501CA93DQ33332191-83D67130-E977-44F8-A5A8-DABC25EB2936Q33625073-7547D110-9225-4852-ABAE-CAD86B695133Q33784852-FA0E01E4-1659-48F4-AC0F-9F0258A2A5C2Q33818024-E275186A-DFDF-4C76-A0F0-519F2B9EE503Q33821257-F4E4532B-9424-46DB-BDB3-7DDF5D805639Q33963580-7AFCD30E-9BBE-460D-8C90-2A8162C85ABDQ33982161-83024827-649D-4536-BB5A-2706ACE4E7B4Q34034418-6F00B0E4-814F-4C92-8B46-0A010AD05026Q34399535-3BE44CD1-7558-4F8F-B46E-CB8C8492201EQ34478248-9409D6C3-EA26-40FD-9439-E9238F3FA236Q34506545-B16E81E4-4C53-4ED9-A654-50FB59A27943Q34736553-8BE70272-8582-42A0-900F-72A9D00A1AF6Q35003539-BD979D9D-635B-4FC4-AE30-845284476EC4Q35021555-B0E30309-D774-4BD6-9B61-5B8B8DB5F94DQ35033732-804DEEAA-D19B-47C2-B530-52654252F0E4Q35077568-1C0709DD-3BF7-45D7-835C-8A5D3C03EA9CQ35140323-4E2CCB0E-8128-4809-9BEE-98DE9D91F87D
P2860
Chemoprophylaxis with tenofovir disoproxil fumarate provided partial protection against infection with simian human immunodeficiency virus in macaques given multiple virus challenges.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Chemoprophylaxis with tenofovi ...... ven multiple virus challenges.
@en
Chemoprophylaxis with tenofovi ...... ven multiple virus challenges.
@nl
type
label
Chemoprophylaxis with tenofovi ...... ven multiple virus challenges.
@en
Chemoprophylaxis with tenofovi ...... ven multiple virus challenges.
@nl
prefLabel
Chemoprophylaxis with tenofovi ...... ven multiple virus challenges.
@en
Chemoprophylaxis with tenofovi ...... ven multiple virus challenges.
@nl
P2093
P356
P1476
Chemoprophylaxis with tenofovi ...... ven multiple virus challenges.
@en
P2093
Alan E Greenberg
Ana Rendon
Artur Ramos
Debra R Adams
Eddie Jackson
Jeffrey Johnson
Lynn Paxton
Michael G Hudgens
Michael Monsour
P304
P356
10.1086/507306
P407
P577
2006-08-29T00:00:00Z